Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (RACHEL)

Tracking Information
First Submitted Date	June 30, 2009
First Posted Date	July 2, 2009
Last Update Posted Date	October 27, 2009
Study Start Date	July 2009
Primary Completion Date	Not Provided
Current Primary Outcome Measures; (submitted: July 1, 2009)	Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment) [ Time Frame: After Treatment : at least 4 weeks before statin taking /Baseline : no limitation. ]
Original Primary Outcome Measures	Same as current
Change History	Complete list of historical versions of study NCT00931320 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures; (submitted: July 1, 2009)	Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment) [ Time Frame: After Treatment : at least 4 weeks before statin taking / Baseline : no limitation. ]
Original Secondary Outcome Measures	Same as current
Current Other Outcome Measures	Not Provided
Original Other Outcome Measures	Not Provided
Descriptive Information
Brief Title	Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients
Official Title	Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients
Brief Summary	An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.
Detailed Description	Not Provided
Study Type	Observational
Study Design	Observational Model: Cohort; Time Perspective: Retrospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Who have at least made 1 visit to the outpatient clinic within previous 6 months .
Condition	Dyslipidemias
Intervention	Not Provided
Study Groups/Cohorts	3000 patients; Who have at least made 1 visit to the outpatient clinic within previous 6 months .
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Recruitment Information
Recruitment Status	Completed
Estimated Enrollment; (submitted: July 1, 2009)	3000
Original Estimated Enrollment	Same as current
Actual Study Completion Date	September 2009
Primary Completion Date	Not Provided
Eligibility Criteria	Inclusion Criteria: Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia; Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months; Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking) Exclusion Criteria: Subjects who are unwilling or unable to provide their examination and lab result of medical chart.
Sex/Gender	Sexes Eligible for Study: All
Ages	18 Years and older (Adult, Senior)
Accepts Healthy Volunteers	No
Contacts	Contact information is only displayed when the study is recruiting subjects
Listed Location Countries	Not Provided
Removed Location Countries
Administrative Information
NCT Number	NCT00931320
Other Study ID Numbers	NIS-CKR-DUM-2009/3
Has Data Monitoring Committee	No
U.S. FDA-regulated Product	Not Provided
IPD Sharing Statement	Not Provided
Responsible Party	Hyunah Caroline, Choi / CV TA Physician, AstraZeneca Pharmaceuticals
Study Sponsor	AstraZeneca
Collaborators	Not Provided
Investigators	Study Director: Hyunah Caroline Choi AstraZeneca Korea
PRS Account	AstraZeneca
Verification Date	October 2009